Previous studies have reported that while accumulation of VAT is linked to higher metabolic risk and overall mortality, expansion of subcutaneous AT improves insulin sensitivity and reduces the risk of T2D [41, 42]. The gene discussed is INS; the disease is type 2 diabetes mellitus.